Causes of interruption of bevacizumab therapy in age-related macular degeneration Causas de interrupção do tratamento com bevacizumab em degeneração macular relacionada à idade

Causes of interruption of bevacizumab therapy in age-related macular degeneration Causas de interrupção do tratamento com bevacizumab em degeneração macular relacionada à idade

PURPOSE: To evaluate the rate and the causes of interruption of bevacizumab intravitreal therapy in patients with exudative age-related macular degeneration (AMD) in a referential eye-care center in Joinville, southern Brazil. METHODS: Retrospective, non-comparative, consecutive case series. Cases i...

Full description

Bibliographic Details
Main Authors:	Renata Portella Nunes, Mário Junqueira Nóbrega, Fernando José De Novelli, Samuel Ângelo Coral, Thais Bacha Berti, Marina Maria Drumm Missen, Marina Canuto Correa
Format:	Article
Language:	English
Published:	Conselho Brasileiro de Oftalmologia 2010-04-01
Series:	Arquivos Brasileiros de Oftalmologia
Subjects:	Degeneração macular Membrana neovascular sub-retiniana Fator A de crescimento endotelial vascular Inibidores da angiogênese Bevacizumab Macular degeneration Choroidal neovascularization Vascular endothelial growth factor A Angiogenesis inhibitors
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492010000200009

Similar Items

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
by: Hamidreza Torabi, et al.
Published: (2018-01-01)

Associação do polimorfismo Y402H do gene CFH com o tratamento da degeneração macular relacionada à idade com antiangiogênicos
by: Medina, Flavio Mac Cord, 1978-
Published: (2013)

Tratamento da forma neovascular de degeneração macular relacionada à idade com drogas antiangiogênicas Treatment of neovascular age-related macular degeneration with antiangiogenic drugs
by: Eduardo Büchele Rodrigues, et al.
Published: (2006-10-01)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
by: Elad Moisseiev, et al.
Published: (2010-08-01)

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration
by: Shaikh Saad, et al.
Published: (2007-01-01)

Comparison of ranibizumab and bevacizumab in neovascular age-related macular degeneration
by: Huseyin Serdarogullari, et al.
Published: (2014-05-01)

Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
by: Zhe-Li Liu, et al.
Published: (2013-04-01)

The effects of the subconjunctival injection of bevacizumab (Avastin®) on angiogenesis in the rat cornea
by: Luiz F.M. Barros, et al.
Published: (2007-09-01)

Aqueous vascular endothelial growth factor and clinical outcomes correlation after single intravitreal injection of bevacizumab in patients with neovascular age-related macular degeneration
by: Thiago Cabral, et al.
Published: (2017-05-01)

Incidence of anterior segment neovascularization during intravitreal treatment for macular edema secondary to central retinal vein occlusion
by: Luiz Filipe Adami Lucatto, et al.

Bevacizumab versus ranibizumab for neovascular age-related macular degeneration:a Meta-analysis
by: Wen-Jie Wang, et al.
Published: (2015-02-01)

Clinical observation of bevacizumab(avastin)for treating age-related macular degeneration
by: Zhi-Guang Duan, et al.
Published: (2014-06-01)

Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration Ranibizumab e bevacizumab intravítreo no tratamento da neovascularização de coróide extrafoveal da degeneração macular relacionada à idade
by: Aaron Brock Roller, et al.
Published: (2009-10-01)

6-weekly bevacizumab versus 4-weekly ranibizumab for neovascular age-related macular degeneration: a 2-year outcome
by: Patrick J Chiam, et al.
Published: (2016-04-01)

Degeneração macular relacionada à idade: novas perspectivas Age-related macular degeneration: new perspectives
by: Marcio Bittar Nehemy
Published: (2006-12-01)

Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies
by: Anna A. Plyukhova, et al.
Published: (2020-05-01)

Long-term outcomes of combination photodynamic therapy with ranibizumab or bevacizumab for treatment of wet age-related macular degeneration
by: Ekta Rishi, et al.
Published: (2016-01-01)

Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
by: Anna Krystyna Britton, et al.
Published: (2020-12-01)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
by: Ahmed S Al-Hinai, et al.
Published: (2011-01-01)

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population
by: Kumar Atul, et al.
Published: (2007-01-01)

Evaluation of efficacy of combined intravitreal bevacizumab and grid laser treatment in diabetic macular edema
by: Çetin Akpolat, et al.
Published: (2015-12-01)

Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
by: Joel Hanhart, et al.
Published: (2017-10-01)

Intravítrea de bevacizumab vs. bevacizumab y triamcinolona para el edema macular diabético
by: Ileana Vila Dopico, et al.

Intravitreal bevacizumab for choroidal neovascular membrane associated with Best′s vitelliform dystrophy
by: Rishi Ekta, et al.
Published: (2010-01-01)

The methodological quality of systematic reviews comparing intravitreal bevacizumab and alternates for neovascular age related macular degeneration: A systematic review of reviews
by: Pradeep Paul George, et al.
Published: (2014-01-01)

Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
by: Tuğba Aydoğan, et al.
Published: (2016-12-01)

Effectiveness of monthly and fortnightly anti-VEGF treatments for age-related macular degeneration
by: Renata Portella Nunes, et al.
Published: (2019-02-01)

Intraocular Injection of StivantⓇ (A Biosimilar to Bevacizumab): A Case Series
by: Ahmad Mirshahi, et al.
Published: (2021-01-01)

Intravitreal bevacizumab combined with infliximab in the treatment of choroidal neovascularization secondary to age-related macular degeneration: case report series
by: Luiz Guilherme Azevedo de Freitas, et al.
Published: (2013-06-01)

Photodynamic therapy and intravitreal bevacizumab with versus without triamcinolone for neovascular age-related macular degeneration; a randomized clinical trial
by: Niloofar Piri, et al.
Published: (2014-01-01)

Intravitreal injection of Bevacizumab combined retinal photocoagulation for diabetic macular edema
by: Quan-Liang Zhao, et al.
Published: (2013-08-01)

Observation of Bevacizumab intravitreal injection combined with compound trabeculectomy for NVG
by: Bing Wu, et al.
Published: (2018-07-01)

Satisfação do paciente com degeneração macular relacionada à idade após terapia térmica transpupilar Satisfaction of the patient with age-related macular degeneration after transpupillary thermotherapy
by: Jhony de Polo, et al.
Published: (2004-04-01)

Intravitreal Bevacizumab for Pseudophakic Cystoid Macular Edema; a Systematic Review
by: Khalil Ghasemi Falavarjani, et al.
Published: (2012-01-01)

Use of Bevacizumab in the Treatment of Corneal Neovascularization
by: Tuba Çelik, et al.
Published: (2015-01-01)

Evaluation of Aqueous Flare Intensity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular Age-Related Macular Degeneration
by: Joanna Dolar-Szczasny, et al.
Published: (2021-04-01)

Comparison of intravitreal bevacizumab and triamcinolone acetonide theraphies for diffuse diabetic macular edema
by: Sibel Aksoy, et al.
Published: (2015-06-01)

Effect of intravitreal bevacizumab on subfoveal choroidal thickness in eyes with diabetic macular edema
by: Haitham Y Al-Nashar
Published: (2016-01-01)

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
by: Ramin Nourinia, et al.
Published: (2010-01-01)

Intravitreal bevacizumab injection in the treatment of macular edema secondary to branch retinal vein occlusion
by: Şeref İstek, et al.
Published: (2014-06-01)